PURPOSE:Elevated intracranial pressure (ICP) has been associated with increased mortality in patients with severe traumatic brain injury (TBI). We have examined whether raised ICP is independently associated with mortality, functional status and neuropsychological functioning in adult TBI patients. METHODS: Data from a randomized trial of 499 participants were secondarily analyzed. The primary endpoints were mortality and a composite measure of functional status and neuropsychological function (memory, speed of information processing, executive function) over a 6-month period. The area under the curve of the ICP profile (average ICP) during the first 48 h of monitoring was the main predictor of interest. Multivariable regression was used to adjust for a priori defined confounders: age, Glasgow Coma Score, Abbreviated Injury Scale-head and hypoxia. RESULTS: Of the participants, 365 patients had complete 48-h ICP data. The overall 6-month mortality was 18 %. The adjusted odds ratio of mortality comparing 10-mmHg increases in average ICP was 3.12 (95 % confidence interval 1.79, 5.44; p < 0.01). Overall, higher average ICP was associated with decreased functional status and neuropsychological functioning (p < 0.01). Importantly, among survivors, increasing average ICP was not independently associated with worse performance on neuropsychological testing (p = 0.46). CONCLUSIONS:Average ICP in the first 48 h of monitoring was an independent predictor of mortality and of a composite endpoint of functional and neuropsychological outcome at the 6-month follow-up in moderate or severe TBI patients. However, there was no association between average ICP and neuropsychological functioning among survivors.
RCT Entities:
PURPOSE: Elevated intracranial pressure (ICP) has been associated with increased mortality in patients with severe traumatic brain injury (TBI). We have examined whether raised ICP is independently associated with mortality, functional status and neuropsychological functioning in adult TBIpatients. METHODS: Data from a randomized trial of 499 participants were secondarily analyzed. The primary endpoints were mortality and a composite measure of functional status and neuropsychological function (memory, speed of information processing, executive function) over a 6-month period. The area under the curve of the ICP profile (average ICP) during the first 48 h of monitoring was the main predictor of interest. Multivariable regression was used to adjust for a priori defined confounders: age, Glasgow Coma Score, Abbreviated Injury Scale-head and hypoxia. RESULTS: Of the participants, 365 patients had complete 48-h ICP data. The overall 6-month mortality was 18 %. The adjusted odds ratio of mortality comparing 10-mmHg increases in average ICP was 3.12 (95 % confidence interval 1.79, 5.44; p < 0.01). Overall, higher average ICP was associated with decreased functional status and neuropsychological functioning (p < 0.01). Importantly, among survivors, increasing average ICP was not independently associated with worse performance on neuropsychological testing (p = 0.46). CONCLUSIONS: Average ICP in the first 48 h of monitoring was an independent predictor of mortality and of a composite endpoint of functional and neuropsychological outcome at the 6-month follow-up in moderate or severe TBIpatients. However, there was no association between average ICP and neuropsychological functioning among survivors.
Authors: Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright Journal: J Neurotrauma Date: 2007 Impact factor: 5.269
Authors: A L Maset; A Marmarou; J D Ward; S Choi; H A Lutz; D Brooks; R J Moulton; A DeSalles; J P Muizelaar; H Turner Journal: J Neurosurg Date: 1987-12 Impact factor: 5.115
Authors: R K Narayan; P R Kishore; D P Becker; J D Ward; G G Enas; R P Greenberg; A Domingues Da Silva; M H Lipper; S C Choi; C G Mayhall; H A Lutz; H F Young Journal: J Neurosurg Date: 1982-05 Impact factor: 5.115
Authors: Nancy R Temkin; Gail D Anderson; H Richard Winn; Richard G Ellenbogen; Gavin W Britz; James Schuster; Timothy Lucas; David W Newell; Pamela Nelson Mansfield; Joan E Machamer; Jason Barber; Sureyya S Dikmen Journal: Lancet Neurol Date: 2007-01 Impact factor: 44.182
Authors: Franck Amyot; David B Arciniegas; Michael P Brazaitis; Kenneth C Curley; Ramon Diaz-Arrastia; Amir Gandjbakhche; Peter Herscovitch; Sidney R Hinds; Geoffrey T Manley; Anthony Pacifico; Alexander Razumovsky; Jason Riley; Wanda Salzer; Robert Shih; James G Smirniotopoulos; Derek Stocker Journal: J Neurotrauma Date: 2015-09-30 Impact factor: 5.269
Authors: George P Liao; Matthew T Harting; Robert A Hetz; Peter A Walker; Shinil K Shah; Christopher J Corkins; Travis G Hughes; Fernando Jimenez; Steven C Kosmach; Mary-Clare Day; KuoJen Tsao; Dean A Lee; Laura L Worth; James E Baumgartner; Charles S Cox Journal: Pediatr Crit Care Med Date: 2015-03 Impact factor: 3.624
Authors: Brandon Foreman; Laura B Ngwenya; Erica Stoddard; Jason M Hinzman; Norberto Andaluz; Jed A Hartings Journal: Neurocrit Care Date: 2018-12 Impact factor: 3.210
Authors: Ruchira M Jha; Shashvat M Desai; Benjamin E Zusman; Theresa A Koleck; Ava M Puccio; David O Okonkwo; Seo-Young Park; Lori A Shutter; Patrick M Kochanek; Yvette P Conley Journal: J Neurotrauma Date: 2019-02-01 Impact factor: 5.269